Senti Biosciences Holdings, Inc. Completes Acquisition of Senti Biosciences, Inc.
Acquiring Company
Senti Biosciences
Acquired Company
Senti Biosciences
South San FranciscoSouth San FranciscoBiotechnologyBiotechnologyDescription
On October 21, 2026, Senti Biosciences Holdings, Inc. completed the acquisition of Senti Biosciences, Inc. This strategic move is aligned with their vision to expand their portfolio in gene and cell therapies. This merger is expected to enhance their capabilities and market presence significantly. The company has initiated the distribution of contingent value rights in connection with this transaction.
Who to call at Senti Biosciences, and when
When Senti Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Senti Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Senti Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Senti Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Senti Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Senti Biosciences?
Senti Biosciences was acquired by Senti Biosciences, based in South San Francisco. The deal was reported on October 27, 2026. Senti Biosciences, Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform. Senti Biosciences is publicly traded (SNTI) and operates in Biotechnology.
When did Senti Biosciences acquire Senti Biosciences?
Senti Biosciences's acquisition of Senti Biosciences was reported on October 27, 2026. On October 21, 2026, Senti Biosciences Holdings, Inc. completed the acquisition of Senti Biosciences, Inc. This strategic move is aligned with their vision to expand their portfolio in gene and cell therapies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Senti Biosciences do?
Senti Biosciences, Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform. It is publicly traded (SNTI), operating in Biotechnology, and is based in South San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.